United States· US:70515-500_daa4568e-f725-4df3-85eb-ff0ede789c78
Sular
A nisoldipine product containing nisoldipine, registered in United States by Covis Pharma US, Inc. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Nisoldipine is registered in 4 of 19 countries.
Countries holding a registration under ATC C08CA07 (nisoldipine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Nisoldipine · ATC C08CA07
4 / 19 countries
- Belgiumprice
- Finlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NISOLDIPINE
- Manufacturer
- Covis Pharma US, Inc
- Country
- United States (US)
- ATC code
- C08CA07
- ATC class
- Nisoldipine
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1170515500101 BOTTLE in 1 CARTON (70515-500-10) / 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
- ndc1170515-500-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
230 interactions on record for nisoldipine.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nisoldipine · interactions on record
230 records
- 10 severe
- 168 moderate
- 5 minor
- 46 info
Most severe, free to view
- DolasetronA04AA04severe
- KetoconazoleH02CA03severe
- KetoconazoleJ02AB02severe
- CeritinibL01ED02severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nisoldipine in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb143099-3769-4e47-ab53-184023e61d50 GET /v1/drugs/fb143099-3769-4e47-ab53-184023e61d50?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "8.5",
"substance": "NISOLDIPINE",
"productndc": "70515-500",
"dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA020356",
"marketing_category": "NDA"
}See everything about nisoldipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.